Skip to content

Opening book details…

About this scholarly article

SAT0212 Sarilumab dose reduction in an open-label extension study in ra patients with inadequate response to tnf inhibitors by Fleischmann, R ;Hrycaj, P ;Hoogstraten, H van ;Mangan, EK ;Lin, Y ;Jayawardena, S ;Burmester, GR is a scholarly article available to read on EtoBox.

Author
Fleischmann, R ;Hrycaj, P ;Hoogstraten, H van ;Mangan, EK ;Lin, Y ;Jayawardena, S ;Burmester, GR
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism
Published
2017

More by Fleischmann, R ;Hrycaj, P ;Hoogstraten, H van ;Mangan, EK ;Lin, Y ;Jayawardena, S ;Burmester, GR

Browse all works by Fleischmann, R ;Hrycaj, P ;Hoogstraten, H van ;Mangan, EK ;Lin, Y ;Jayawardena, S ;Burmester, GR